← Back to Search

Polyphenolic

Mango beverage for Absorption of Chemicals

N/A
Waitlist Available
Led By Susanne Talcott, Ph.D.
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No medical history of digestive disorders or chronic diseases
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

The objective of this research is to characterize the urinary metabolites produced after the consumption of mango pulp in an effort to begin to characterize the bioavailability of the major group of polyphenolics in mango, ester-linked gallic acids, and to provide new insight into their in vivo physiological behavior.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in the levels of metabolites of gallic acid in urine after mango intake.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Mango beverageExperimental Treatment1 Intervention
Mango polyphenolics
Group II: Sugary beveragePlacebo Group1 Intervention
Sugary beverage
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mango polyphenolics
2014
N/A
~20

Find a Location

Who is running the clinical trial?

Texas A&M UniversityLead Sponsor
140 Previous Clinical Trials
24,076 Total Patients Enrolled
Susanne Talcott, Ph.D.Principal InvestigatorTexas A&M University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby May 2025